Mitochondria: a target for cancer therapy

被引:203
作者
Armstrong, JS [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Fac Med, Dept Biochem, Singapore 117597, Singapore
关键词
mitochondria; apoptosis; Bcl-2; Bax; BH3; domain; cancer; mitochondrial membrane permeabilization; mitochondrial permeability transition; reactive oxygen species; cyclosporine A; mitochondrial membrane potential;
D O I
10.1038/sj.bjp.0706556
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mitochondria, the cells powerhouses, are essential for maintaining cell life, and they also play a major role in regulating cell death, which occurs upon permeabilization of their membranes. Once mitochondrial membrane permeabilization (MMP) occurs, cells die either by apoptosis or necrosis. Key factors regulating MMP include calcium, the cellular redox status ( including levels of reactive oxygen species) and the mobilization and targeting to mitochondria of Bcl-2 family members. Contemporary approaches to targeting mitochondria in cancer therapy use strategies that either modulate the action of Bcl-2 family members at the mitochondrial outer membrane or use specific agents that target the mitochondrial inner membrane and the mitochondrial permeability transition (PT) pore. The aim of this review is to describe the major mechanisms regulating MMP and to discuss, with examples, mitochondrial targeting strategies for potential use in cancer therapy.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 50 条
  • [41] Proline Oxidase (POX) as A Target for Cancer Therapy
    Kononczuk, Joanna
    Czyzewska, Urszula
    Moczydlowska, Joanna
    Surazynski, Arkadiusz
    Palka, Jerzy
    Miltyk, Wojciech
    CURRENT DRUG TARGETS, 2015, 16 (13) : 1464 - 1469
  • [42] Talin: A Potential Drug Target for Cancer Therapy
    Malla, Rama Rao
    Vempati, Rahul Kumar
    CURRENT DRUG METABOLISM, 2020, 21 (01) : 25 - 32
  • [43] Angiogenesis as a potential target of pharmaconutrients in cancer therapy
    Granci, Virginie
    Dupertuis, Yves M.
    Pichard, Claude
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04) : 417 - 422
  • [44] Mitochondria: a target for myocardial protection
    Suleiman, MS
    Halestrap, AP
    Griffiths, EJ
    PHARMACOLOGY & THERAPEUTICS, 2001, 89 (01) : 29 - 46
  • [45] Mitochondrial permeability transition pore as a selective target for anti-cancer therapy
    Suh, Dong H.
    Kim, Mi-Kyung
    Kim, Hee S.
    Chung, Hyun H.
    Song, Yong S.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [46] Approaches for targeting mitochondria in cancer therapy
    D'Souza, Gerard G. M.
    Wagle, Mayura A.
    Saxena, Vaibhav
    Shah, Anee
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2011, 1807 (06): : 689 - 696
  • [47] A mitochondria targeting Mn nanoassembly of BODIPY for LDH-A, mitochondria modulated therapy and bimodal imaging of cancer
    Boison, Daniel
    Lu, Wen-Long
    Xu, Qin-Mei
    Yang, Huang
    Huang, Tao
    Chen, Qiu-Yun
    Gao, Jing
    Zhao, Yao
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 147 : 387 - 396
  • [48] Editorial: The proceedings of mitochondria apoptosis and cancer (MAC 2021) virtual symposium
    Pervaiz, Shazib
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 10
  • [49] Mitochondria: A target for neuroprotective interventions in cerebral ischemia-reperfusion
    Chtistophe, M
    Nicolas, S
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (06) : 739 - 757
  • [50] Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger
    Ralph, Stephen J.
    Rodriguez-Enriquez, Sara
    Neuzil, Jiri
    Moreno-Sanchez, Rafael
    MOLECULAR ASPECTS OF MEDICINE, 2010, 31 (01) : 29 - 59